Drug
Mirogabalin clinical trials
Also written DS-5565.
- studies test it
- 17
- open now
- 4
- in phase 3
- 9
- first study started
- 2011
Keep track of what changes. Save the mirogabalin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
17 studies that test it; most in 2015 (6)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 6 |
| 2019 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 3
- 9
- Phase 4
- 1
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 5
Daiichi Sankyo Co., Ltd. (6) · Daiichi Sankyo (6) · Pusan National University Yangsan Hospital (1) · Cairo University (1) · Thammasat University Hospital (1) · Beijing Tiantan Hospital (1) · Bangladesh Medical University (1)
Studies
Open first, then newest update. How each study uses mirogabalin is read from its arms, and is right about nine times in ten.
Testing it · 17
- Perioperative Mirogabalin for Pain Relief After Modified Radical MastectomyNot yet recruitingNot applicableCairo UniversityNCT07880821Written as Mirogabalin
- Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKARecruitingNot applicableThammasat University HospitalNCT06328062Written as Mirogabalin
- The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With FibromyalgiaRecruitingNot applicableBeijing Tiantan HospitalNCT07157852Written as Mirogabalin
- Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic PainRecruitingPhase 4Bangladesh Medical UniversityNCT07451431Written as Mirogabalin
- Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer SurvivorsCompletedNot applicablePusan National University Yangsan HospitalNCT06711978Written as Mirogabalin
- Study of Mirogabalin for Central Neuropathic PainCompletedPhase 3Daiichi Sankyo Co., Ltd.NCT03901352Written as Mirogabalin
- A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic PainCompletedPhase 3Daiichi Sankyo Co., Ltd.NCT04094662Written as Mirogabalin
- DS-5565 Phase III Study for Renal Impairment in Japanese SubjectsCompletedPhase 3Daiichi Sankyo Co., Ltd.NCT02607280Written as DS-5565
- Treatment of Neuropathic Pain Associated With Diabetic Peripheral NeuropathyCompletedPhase 2Daiichi SankyoNCT01496365Written as DS-5565 tablet
- Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney DiseaseCompletedPhase 3Daiichi SankyoNCT02496884Written as DS-5565
- Treatment of Pain Associated With FibromyalgiaCompletedPhase 3Daiichi SankyoNCT02146430Written as DS-5565
- Treatment of Pain Associated With FibromyalgiaCompletedPhase 3Daiichi SankyoNCT02187159Written as DS-5565
- Treatment of Pain Associated With FibromyalgiaCompletedPhase 3Daiichi SankyoNCT02187471Written as DS-5565
- DS-5565 Phase III Study for Diabetic Peripheral Neuropathic PainCompletedPhase 3Daiichi Sankyo Co., Ltd.NCT02318706Written as DS-5565
- DS-5565 Phase III Study for Post-herpetic NeuralgiaCompletedNot applicableDaiichi Sankyo Co., Ltd.NCT02318719Written as DS-5565
- An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With FibromyalgiaCompletedPhase 3Daiichi SankyoNCT02234583Written as DS-5565
- Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral NeuropathyCompletedPhase 2Daiichi Sankyo Co., Ltd.NCT01504412Written as DS-5565
Given in every arm · 1 — mirogabalin is usual care beside what is tested
Codes
What other systems call mirogabalin · ClinicalTrials.gg INT000242
- MeSH (NLM) C000598618mirogabalinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) S7LK2KDM5UMIROGABALINConfirmed FDA, NLM, Wikidata
- Wikidata Q20706932mirogabalinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C170186MirogabalinOne source FDA
- DrugBank DB11825One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000598618 | mirogabalin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | S7LK2KDM5U | MIROGABALIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q20706932 | mirogabalin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C170186 | Mirogabalin | One source FDA |
| DrugBank | DB11825 | — | One source Wikidata |
Also registered as mirogabalin besylate (UNII 01F4FRP8YL).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.